- Home
- PAA vs ASND Comparison
PAA vs ASND Comparison
Compare PAA & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAA
- ASND
- Stock Information
- Founded
- PAA 1981
- ASND 2006
- Country
- PAA United States
- ASND Denmark
- Employees
- PAA N/A
- ASND N/A
- Industry
- PAA Natural Gas Distribution
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- PAA Energy
- ASND Health Care
- Exchange
- PAA Nasdaq
- ASND Nasdaq
- Market Cap
- PAA 12.0B
- ASND 12.2B
- IPO Year
- PAA N/A
- ASND 2015
- Fundamental
- Price
- PAA $16.87
- ASND $218.46
- Analyst Decision
- PAA Hold
- ASND Strong Buy
- Analyst Count
- PAA 12
- ASND 17
- Target Price
- PAA $20.18
- ASND $245.76
- AVG Volume (30 Days)
- PAA 3.1M
- ASND 492.4K
- Earning Date
- PAA 11-05-2025
- ASND 11-12-2025
- Dividend Yield
- PAA 9.02%
- ASND N/A
- EPS Growth
- PAA 7.88
- ASND N/A
- EPS
- PAA 1.21
- ASND N/A
- Revenue
- PAA $46,917,000,000.00
- ASND $758,592,045.00
- Revenue This Year
- PAA N/A
- ASND $104.98
- Revenue Next Year
- PAA $5.89
- ASND $79.91
- P/E Ratio
- PAA $13.88
- ASND N/A
- Revenue Growth
- PAA N/A
- ASND 97.46
- 52 Week Low
- PAA $15.58
- ASND $118.03
- 52 Week High
- PAA $21.00
- ASND $223.19
- Technical
- Relative Strength Index (RSI)
- PAA 55.76
- ASND 64.35
- Support Level
- PAA $16.50
- ASND $188.07
- Resistance Level
- PAA $17.12
- ASND $202.41
- Average True Range (ATR)
- PAA 0.34
- ASND 9.60
- MACD
- PAA 0.06
- ASND 1.08
- Stochastic Oscillator
- PAA 78.02
- ASND 86.10
About PAA Plains All American Pipeline L.P.
Plains All American Pipeline LP through its subsidiaries, engages in the pipeline transportation, terminaling, storage, and gathering of crude oil and natural gas liquids (NGL) in the United States and Canada. The company operates through two segments, Crude Oil and NGL. The Crude Oil segment offers gathering and transporting crude oil through pipelines, gathering systems, trucks, and barges or railcars. The NGL segment is involved in natural gas processing and NGL fractionation, storage, transportation, and terminalling. It generates the majority of its revenue from the Crude Oil segment.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.